Response to Letter of Li et al.: How to select antiplatelet therapy in patients with acute coronary syndrome, according to platelet function testing or pharmacogenomic testing?
- PMID: 30223360
- DOI: 10.1016/j.ijcard.2018.06.048
Response to Letter of Li et al.: How to select antiplatelet therapy in patients with acute coronary syndrome, according to platelet function testing or pharmacogenomic testing?
Comment on
-
High on-treatment platelet reactivity and outcome in elderly with non ST-segment elevation acute coronary syndrome - Insight from the GEPRESS study.Int J Cardiol. 2018 May 15;259:20-25. doi: 10.1016/j.ijcard.2018.01.057. Int J Cardiol. 2018. PMID: 29579602
-
How to select antiplatelet therapy in patients with acute coronary syndrome, according to platelet function testing or pharmacogenomic testing?Int J Cardiol. 2018 Nov 15;271:28. doi: 10.1016/j.ijcard.2018.05.121. Int J Cardiol. 2018. PMID: 30223357 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
